Search Results - David Frederick
- Showing 1 - 9 results of 9
-
1
-
2
The biosynthesis of alginic acid by <i>Azotobacter vinelandii</i> by David Frederick. Pindar, C. Bucke
Published 1975Artigo -
3
-
4
-
5
Inhibition of Release of Vasoactive and Inflammatory Mediators in Airway and Vascular Tissues and Macrophages By a Chinese Herbal Medicine Formula for Allergic Rhinitis by Lenon, George Binh, Li, Chun Guang, Xue, Charlie Changli, Thien, Francis Chung Kong, Story, David Frederick
Published 2007Text -
6
-
7
Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B by Maureen M. Jonas, Déirdre Kelly, Henry Pollack, J. Mizerski, J. Sorbel, David Frederick, Elsa Mondou, Franck Rousseau, Étienne Sokal
Published 2008Artigo -
8
Absolute Lymphocyte Count Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome by Haesook T. Kim, Philippe Armand, David Frederick, Emily Andler, Corey Cutler, John Koreth, Edwin P. Alyea, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz, Vincent T. Ho
Published 2015Artigo -
9
Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus Infection by Thomas Berg, Patrick Marcellin, Fabien Zoulim, Bernd Möller, Huy N. Trinh, Sing Chan, Emilio Suárez, Fabien Lavocat, Andrea Snow‐Lampart, David Frederick, J. Sorbel, Katyna Borroto–Esoda, David Oldach, Franck Rousseau
Published 2010Artigo
Search Tools:
Related Subjects
Medicine
Gastroenterology
Internal medicine
Adefovir
Biology
Genetics
Hepatitis B
Hepatitis B virus
Lamivudine
Virus
Adverse effect
Alginic acid
Alternative medicine
Azotobacter
Azotobacter vinelandii
Bacteria
Biochemistry
Biosynthesis
Chemistry
Clinical endpoint
Clinical trial
Cohort
Combination therapy
Commission
Confidence interval
Emtricitabine
Engineering
Environmental health
Enzyme
Excellence